XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.2

Revenue (Tables)

9 Months Ended

Jul. 31, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

	Three Months Ended July 31, 2019
	Life Sciences and Applied Markets				Diagnostics and Genomics				Agilent CrossLab				Total
	(in millions)
Revenue by Region
Americas	$	160			$	138			$	167			$	465
Europe	118				91				130				339
Asia Pacific	266				34				170				470
Total	$	544			$	263			$	467			$	1,274
	Nine Months Ended July 31, 2019
	Life Sciences and Applied Markets				Diagnostics and Genomics				Agilent CrossLab				Total
	(in millions)
Revenue by Region
Americas	$	473			$	367			$	491			$	1,331
Europe	407				279				390				1,076
Asia Pacific	800				106				483				1,389
Total	$	1,680			$	752			$	1,364			$	3,796

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

	Three Months Ended				Nine Months Ended
	July 31, 2019				July 31, 2019
	(in millions)
Revenue by End Markets
Pharmaceutical and Biotechnology	$	416			$	1,178
Chemical and Energy	291				899
Diagnostics and Clinical	198				578
Food	116				359
Academia and Government	103				333
Environmental and Forensics	150				449
Total	$	1,274			$	3,796
Revenue by Type
Instrumentation	$	505			$	1,563
Non-instrumentation and other	769				2,233
Total	$	1,274			$	3,796

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the nine months ended July 31, 2019:

		Contract Liabilities
		(in millions)
Ending balance as of October 31, 2018		$	367
Impact of adoption of new revenue recognition guidance		(11		)
Net revenue deferred in the period		263
Revenue recognized that was included in the contract liability balance at the beginning of the period		(230		)
Change in deferrals from customer cash advances, net of revenue recognized		—
Contract liabilities acquired in business combinations		2
Currency translation and other adjustments		—
Ending balance as of July 31, 2019		$	391

X

- Definition

Tabular disclosure of contract balances and changes in contract balances.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration